With more than 25 years of experience, Elissa is driven to use her acumen in development and execution of strategic planning to contribute to Otsuka’s purpose. A visionary by nature, Elissa embodies Otsuka’s core beliefs of perseverance and unconventional thinking through her fierce determination and unwavering commitment to positively impacting change for the future. She is dedicated to finding innovative ways to encourage and motivate those around her. As Vice President, Business Strategy and Planning, she is responsible for evolving Otsuka’s direction through dynamic leadership and alignment.
Prior to joining Otsuka, Elissa served as Senior Vice President, Chief Strategy and Business Development Officer at Mallinckrodt Pharmaceuticals where she was responsible for leading global corporate strategy, licensing and development, M&A, and alliance management through establishing and maintaining industry partnerships. From her time at Mallinckrodt Pharmaceuticals, Elissa has garnered extensive experience and increasing responsibility in her positions as the Head of Global Marketing and Commercial Development, Head of Global Alliance Management and Strategic Programs, and Head of Commercial Gastroenterology. She has also previously assumed several senior leadership roles at pharmaceutical companies, including Medimmune (global biologics division of AstraZeneca), Histogenics Corporation, and Sucampo Pharmaceuticals. Elissa’s beginnings as a strategic and IT management consultant at Accenture, LLP, has only strengthened her drive to create opportunities and defy limitation.
In addition, Elissa is a founding member of Chief, a company for women in executive leadership that was launched in 2019, empowering women and magnifying their influence for positive change. She is also a member of the Licensing Executives Society, and the Pharmaceuticals Global Business Development Heads Roundtable.
Elisa holds a BA in political science from Union College in New York and a Corporate M&A Certification from Columbia Business School.
As Otsuka perseveres forward, it is critical to remember that we are not only committed to innovation but also dedicated to creating positive change in the world. We defy limitation, so others can too.